Shukra Pharmaceuticals fundamental analysis
SHUKRAPHAR
44.2
0.13 (0.29%)Last updated on 25 Aug, 2026 | 12:11 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Shukra Pharmaceuticals Score Card
Price
Expensive
Growth
Good
Quality
Good
Management
Good
On its scorecard, Shukra Pharmaceuticals reflects: Price – Expensive, Growth – Good, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
Shukra Pharmaceuticals Associated Pages
- Shukra Pharmaceuticals
Share Price - Shukra Pharmaceuticals
Share Price chart - Shukra Pharmaceuticals
Technical Analysis - Shukra Pharmaceuticals
Peer Comparison - Shukra Pharmaceuticals
Share Price History - Shukra Pharmaceuticals
Stock Split - Shukra Pharmaceuticals
Dividend - Shukra Pharmaceuticals
Board of Directors - Shukra Pharmaceuticals
Shareholding Pattern
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in SHUKRAPHAR
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Or Download Choice FinX App
Invest in SHUKRAPHAR
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade